Please assess the completion status of the following clinical trial:

Trial Title: Growth Hormone to Increase Immune Function in People With HIV

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV infected~* CD4 count 400 cells/mm3 or less~* HIV viral load less than 1000 copies/ml for 1 year prior to study entry; in some cases, viral load up to 5000 copies/ml will be acceptable~* Taking at least 2 anti-HIV medications~Exclusion Criteria:~* Diabetes~* Cancer. Patients with some cases of Kaposi's sarcoma or skin cancer will not be excluded.~* Some (not all) forms of heart disease~* Carpal Tunnel Syndrome~* Pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Growth Hormone Arm (Type: EXPERIMENTAL): Growth hormone receipt in the first year, post-growth hormone follow-up in the second year
- 2 (Type: ACTIVE_COMPARATOR): Observation only in the 1st year, GH receipt in the second year

Based on this trial design, predict the completion outcome and termination type (if applicable).